Camlin Fine Sciences Limited (NSE:CAMLINFINE)
103.00
+1.44 (1.42%)
Apr 2, 2026, 3:30 PM IST
Camlin Fine Sciences Market Cap
Camlin Fine Sciences has a market cap or net worth of 19.83 billion as of April 2, 2026. Its market cap has decreased by -35.98% in one year.
Market Cap
19.83B
Enterprise Value
24.65B
Revenue
17.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
103.00
Market Cap Chart
Since March 30, 2007, Camlin Fine Sciences's market cap has increased from 412.25M to 19.83B, an increase of 4,709.05%. That is a compound annual growth rate of 22.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 19.51B | -31.53% |
| Dec 31, 2025 | 28.50B | 29.67% |
| Dec 31, 2024 | 21.98B | -3.40% |
| Dec 29, 2023 | 22.75B | -9.51% |
| Dec 30, 2022 | 25.14B | 51.29% |
| Dec 31, 2021 | 16.62B | 6.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advanced Enzyme Technologies | 28.57B |
| NOCIL | 25.66B |
| Tatva Chintan Pharma Chem | 24.62B |
| Sirca Paints India | 22.79B |
| Jubilant Agri and Consumer Products | 22.47B |
| Fineotex Chemical | 22.40B |
| Veedol Corporation | 21.18B |
| Rossari Biotech | 20.97B |